Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTMPZ7V)

DTT Name	Interleukin 13 receptor alpha-2 (IL13RA2) DTT Info
Gene Name	IL13RA2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Download the Complete Related Drug List

1 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Tralokinumab	DM6ENSJ	Atopic dermatitis	EA80	Approved	[1]
------------------------------------------------------------------------------------

3 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ICT-107	DMBIZ7H	Brain cancer	2A00	Phase 3	[2]
ABT-308	DM6WN2D	Eosinophilic esophagitis	DA24.1	Phase 2	[3]
MB-101	DMLA1QD	Recurrent glioblastoma	2A00.00	Phase 1	[4]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model.Am J Respir Cell Mol Biol.2014 May;50(5):985-94.
2	Clinical pipeline report, company report or official report of ImmunoCellular Therapeutics.
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)